Prognostic parameter differences in breast cancer patients between luminal A and luminal B types after application of the new classification according to Ki67 score
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Surgery Open"
DOI: 10.1016/j.ijso.2021.100357
Abstract: Abstract Background The conventional histological classification of breast cancer doesn't provide sufficient information about the biological characteristics and treatment prediction for breast cancer subtypes. Luminal breast cancer has been classified recently according to the expression… read more here.
Keywords: breast cancer; classification; cancer; luminal type ... See more keywords
Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial
Sign Up to like & getrecommendations! Published in 2025 at "BMJ Open"
DOI: 10.1136/bmjopen-2025-102952
Abstract: Introduction Immunotherapy combined with chemotherapy has shown potential in improving the pathological complete response (pCR) rate in luminal-type breast cancer. This study explores whether the addition of stereotactic body radiotherapy (SBRT) and the bispecific antibody… read more here.
Keywords: cancer; luminal type; type breast; trial ... See more keywords
Abstract P4-12-13: Correlation of radiotherapy with the prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p4-12-13
Abstract: Objective:The present study examined the effect of radiotherapy on recurrence and survival in elderly patients with hormone-receptor-positive early breast cancer. Methods:A retrospective analysis of 327 patients aged ≥65 years with stage I-II, hormone receptor positive… read more here.
Keywords: breast; luminal type; radiotherapy; elderly patients ... See more keywords
Association of MammaPrint index and 3-year outcome of patients with HR+HER2- early-stage breast cancer treated with chemotherapy with or without anthracycline.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.511
Abstract: 511 Background: The MammaPrint (MP) risk of distant recurrence signature identifies hormone receptor-positive (HR+), HER2-negative early-stage breast cancer (EBC) patients (pts) with increased or decreased chemosensitivity and chemotherapy (CT) benefit. The MINDACT trial demonstrated excellent… read more here.
Keywords: breast cancer; risk; type; luminal type ... See more keywords
Bone Mineral Density as a Potential Predictive Factor for Luminal-type Breast Cancer in Postmenopausal Women.
Sign Up to like & getrecommendations! Published in 2018 at "Anticancer research"
DOI: 10.21873/anticanres.12561
Abstract: BACKGROUND/AIM We performed a case-control study to evaluate whether bone mineral density (BMD) can be considered a potential predictive factor for luminal-type breast cancer (BC), that could be useful in constructing a predictive risk model.… read more here.
Keywords: potential predictive; bone mineral; luminal type; mineral density ... See more keywords
Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.993466
Abstract: Introduction The molecular subtype plays a significant role in breast carcinoma (BC), which is the main indicator to guide treatment and is closely associated with prognosis. The aim of this study was to investigate the… read more here.
Keywords: luminal non; rad score; non luminal; luminal type ... See more keywords
Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms18020467
Abstract: Panel-based next generation sequencing (NGS) is currently preferred over whole exome sequencing (WES) for diagnosis of familial breast cancer, due to interpretation challenges caused by variants of uncertain clinical significance (VUS). There is also no… read more here.
Keywords: exome sequencing; breast; luminal type; family ... See more keywords
Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Neoplasma"
DOI: 10.4149/neo_2022_220615n635
Abstract: Globally, breast cancer is the main cause of death among female cancer patients. The tumor-infiltrating lymphocytes (TILs) in breast cancer are associated with a more favorable outcome of a disease. Natural killer (NK) cells are… read more here.
Keywords: status; breast cancer; tumor; cancer ... See more keywords